Health Canada endorsed important safety information on propofol injectable emulsion 1% (10mg/mL), 1g/100mL

Hospira Healthcare Corporation is bringing to your immediate attention, a recall of one lot of Propofol Injectable Emulsion 1%, 10mg/mL, lot 09029DJ (expiry date 2014/09/01), that was initiated on September 7, 2012. The recall has been initiated due to the presence of visible particles (metallic and elastomeric) identified in a propofol vial. Hospira has not received any reports of adverse events associated with Propofol Injectable Emulsion 1% (10mg/mL) from its customers. Hospira has initiated investigations to determine the root cause and corrective and preventive actions. Read more here.